Emboline is a series c plus startup based in United States. 1 investor tracked.
Emboline is a company founded in 2018 headquartered in the United States. Its most recent tracked round is Series-c-plus. Brouky records 1 investor associated with the company.
stroke reduction platform caused by embolic debris released during transcatheter heart procedures
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.